FSD*
HHSOtherHealthcareAugust 1, 2019

THE EPIDEMIOLOGY AND LABORATORY CAPACITY FOR PREVENTION AND CONTROL OF EMERGING INFECTIOUS DISEASES(ELC)

$1,643,859,160

Recipient

CITY OF NEW YORK

NY

AI Summary

This $1.6 billion cooperative agreement from HHS funds the City of New York's epidemiology and laboratory capacity for preventing and controlling emerging infectious diseases. Given New York City's large and dense population, this funding is critical for maintaining robust disease surveillance and rapid outbreak response capabilities.

Key Points

  1. 01Funded at approximately $1.6 billion through the ELC program
  2. 02Supports infectious disease prevention in New York City specifically
  3. 03Active from August 2019 through July 2027
  4. 04Separate from New York State's ELC funding
  5. 05Critical for disease surveillance in the nation's most populous city

Award Details

Start Date

Aug 1, 2019

End Date

Jul 31, 2027

Category

Healthcare

State

NY

Award Type

Other

Official Source

View on USAspending.gov

Quick Summary

Amount
$1.6B
Agency
Department of Health and Human Services
Recipient
CITY OF NEW YORK
Type
Other

From the Civic Digest Network

Executive Order Digest

Track and understand presidential executive orders and their impact.

Visit

Federal Regulation Digest

Monitor new and proposed federal regulations across all agencies.

Visit